scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M200102200 |
P698 | PubMed publication ID | 11823472 |
P2093 | author name string | Thomas C Chiles | |
Cheryl Doughty | |||
Michael J Piatelli | |||
P2860 | cites work | Role of tyrosine kinases in lymphocyte activation | Q40626237 |
Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen | Q40822193 | ||
Analysis of site-specific phosphorylation of the retinoblastoma protein during cell cycle progression. | Q40964495 | ||
Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase | Q41093702 | ||
Disruption of the Raf-1-Hsp90 Molecular Complex Results in Destabilization of Raf-1 and Loss of Raf-1-Ras Association | Q41282697 | ||
p21-containing cyclin kinases exist in both active and inactive states | Q41451975 | ||
Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system | Q41483751 | ||
Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes | Q42122378 | ||
Multiple ras effector pathways contribute to G(1) cell cycle progression | Q42812883 | ||
Geldanamycin-induced destabilization of Raf-1 involves the proteasome | Q42834381 | ||
Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen Receptor. | Q44983668 | ||
Cyclin D1 provides a link between development and oncogenesis in the retina and breast | Q52206604 | ||
Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation. | Q54001263 | ||
Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway | Q57589068 | ||
BCR signals target p27Kip1 and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells | Q59102114 | ||
Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development | Q59102116 | ||
Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases | Q73316457 | ||
Bruton's tyrosine-kinase-deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4 | Q74601268 | ||
Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. | Q24529832 | ||
p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function | Q24554532 | ||
Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1) | Q24685138 | ||
A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells | Q24799869 | ||
Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent | Q27736012 | ||
CDK inhibitors: positive and negative regulators of G1-phase progression | Q27860983 | ||
Xid-like phenotypes: a B cell signalosome takes shape | Q28143004 | ||
Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1 | Q28145116 | ||
The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes | Q28207229 | ||
Cyclin D1 is a nuclear protein required for cell cycle progression in G1 | Q28269145 | ||
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization | Q28290083 | ||
Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway | Q28379145 | ||
PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo | Q28609356 | ||
D-type cyclin-dependent kinase activity in mammalian cells | Q29614966 | ||
G1 phase progression: cycling on cue | Q29615162 | ||
Identification of a novel inhibitor of mitogen-activated protein kinase kinase | Q29616448 | ||
Signal transduction from the B cell antigen-receptor | Q33664755 | ||
Signal transduction pathways that regulate the fate of B lymphocytes. | Q33683189 | ||
Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle | Q34076834 | ||
p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2. | Q34377527 | ||
Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion | Q35107957 | ||
Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes | Q36368254 | ||
Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase. | Q36401603 | ||
Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). | Q38319947 | ||
Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression | Q38489869 | ||
The regulated expression of cell cycle-related proteins as B-lymphocytes enter and progress through the G1 cell cycle stage following delivery of complete versus partial activation stimuli | Q39114678 | ||
Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes | Q39574223 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | molecular chaperones | Q422496 |
P304 | page(s) | 12144-12150 | |
P577 | publication date | 2002-01-31 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes | |
P478 | volume | 277 |
Q38406110 | 3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation |
Q36184995 | A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice |
Q28273877 | A comparison of Hsp90alpha and Hsp90beta interactions with cochaperones and substrates |
Q28387056 | Aging and immune function: molecular mechanisms to interventions |
Q35085510 | Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets |
Q42520496 | Critical role of the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway in recovery from anthrax lethal toxin-induced cell cycle arrest and MEK cleavage in macrophages |
Q37463711 | Di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate inhibit growth and reduce estradiol levels of antral follicles in vitro. |
Q35723770 | ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets |
Q36429542 | HSP90: a rising star on the horizon of anticancer targets |
Q37286051 | Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells |
Q37081794 | Heat shock proteins: essential proteins for apoptosis regulation |
Q35056222 | Heat-shock protein 90 alpha (HSP90α) modulates signaling pathways towards tolerance of oxidative stress and enhanced survival of hepatocytes of Mugil cephalus |
Q40381986 | Hsp90alpha recruited by Sp1 is important for transcription of 12(S)-lipoxygenase in A431 cells |
Q42440167 | Medulloblastoma Sensitivity to 17-Allylamino-17-demethoxygeldanamycin Requires MEK/ERK |
Q90399266 | Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma |
Q37872269 | Novel molecular targeted therapies for refractory thyroid cancer |
Q28580810 | O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2 |
Q37024066 | Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein |
Q37415251 | Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin |
Q35014068 | Regulation of B-cell fate by antigen-receptor signals |
Q36838567 | Regulation of cytosolic phospholipase A2alpha by hsp90 and a p54 kinase in okadaic acid-stimulated macrophages |
Q42206552 | Ritonavir binds to and downregulates estrogen receptors: molecular mechanism of promoting early atherosclerosis |
Q36539025 | Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin |
Q45415224 | Signature patterns revealed by microarray analyses of mice infected with influenza virus A and Streptococcus pneumoniae |
Q28301955 | The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition |
Q37293018 | The levels of retinoic acid-inducible gene I are regulated by heat shock protein 90-alpha |
Q35791991 | Therapeutic and diagnostic implications of Hsp90 activation |
Q35848258 | ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia |
Search more.